Night-time work predisposes to non-Hodgkin lymphoma

International Journal of Cancer

Volumn 123, Issue 9, 2008, Pages 2148-2151

  Lahti, Tuuli A ^a   Partonen, Timo ^a   Kyyrönen, Pentti ^b   Kauppinen, Timo ^b   Pukkala, Eero ^c  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^c FINNISH CANCER REGISTRY   (Finland)

Author keywords

Circadian clock; Night time shift work; Non Hodgkin lymphoma

Indexed keywords

ADULT; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; COHORT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NIGHT WORK; NONHODGKIN LYMPHOMA; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; AGED; CIRCADIAN RHYTHM; MIDDLE AGED; PERSONNEL MANAGEMENT; PHYSIOLOGY; RISK; SEXUAL DEVELOPMENT; TIME; WORK SCHEDULE;

AGED; CIRCADIAN RHYTHM; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PERSONNEL STAFFING AND SCHEDULING; RISK; SEX CHARACTERISTICS; TIME FACTORS; WORK SCHEDULE TOLERANCE;

EID: 51649089403     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23566     Document Type: Article

References (31)

1. McKean-Cowdin R, Feigelson HS, Ross RK, Pike MC, Henderson BE. Declining cancer rates in the 1990s. J Clin Oncol 2000;18:2258-68.
2. Clarke CA, Glaser SL. Changing incidence of non-Hodgkin lymphomas in the United States. Cancer 2002;94:2015-23.
3. Müller AMS, Ihorst G, Mertelsmann R, Engelhardt M. Epidemiology of non-Hodgkin's lymphoma (NHL): trends, georraphic distribution, and etiology. Ann Hematol 2005;84:1-12.
4. Sandin S, Hjalgrim H, Glimelius B, Rostgaard K, Pukkala E, Askling J. Incidence of non-Hodgkin's lymphoma in Sweden. Denmark, and Finland from 1960 through 2003: an epidemic that was. Cancer Epidemiol Biomarkers Prev 2006;15:1295-300.
5. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia. November, 1997. Ann Oncol 1999;10:1419-32.
6. Fisher SG, Fisher RI. The epidemiology of non-Hodgkin's lymphoma. Oncogene 2004;23:6524-34.
7. Zhu Y, Leaderer D, Guss C, Brown HN, Zhang Y, Boyle P, Stevens RG, Hoffman A, Qin Q, Han X, Zheng T Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non-Hodgkin's lymphoma. Int J Cancer 2007;120:432-5
8. Chen Z, Odstrcil EA, Tu BP, McKnight SL. Restriction of DNA replication to the reductive phase of the metabolic cycle protects genome integrity. Science 2007;316:1916-9.
9. Méndez-Ferrer S, Lucas D, Battista M, Frenette PS. Haematopoietic stem cell release is regulated by circadian oscillations. Nature 2008;452:442-7.
10. Sun Y, Yang Z, Niu Z, Peng J, Li Q, Xiong W, Langnas AN, Ma MY, Zhao Y. MOP3, a component of the molecular clock, regulates the development of B cells. Immunology 2006;119:451-60.
11. Fu L, Pelicano H, Liu J, Huang P, Lee C. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 2002;111:41-50.
12. Kornmann B, Schaad O, Bujard H, Takahashi JS, Schibler U. System-driven and oscillator-dependent circadian transcription in mice with a conditionally active liver clock. PLoS Biol 2007;5:e34.
13. Zhu Y, Stevens RG, Leaderer D, Hoffman A, Holford T, Zhang Y, Brown HN, Zheng T. Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk. Breast Cancer Res Treat 2008;107:421-5.
14. Central Statistical Office of Finland. Population census 1970: occupation and social position. Official Statistics of Finland VI C: 104, vol. 9. Helsinki: Central Statistical Office of Finland, 1974.
15. Teppo L, Pukkala E, Lehtonen M. Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol 1994;33:365-9.
16. Kauppinen T, Toikkanen J, Pukkala E. From cross-tabulations to multipurpose exposure information systems: a new job-exposure matrix. Am J Ind Med 1998;33:409-17.
17. Kruijver FP, Swaab DF. Sex hormone receptors are present in the human suprachiasmatic nucleus. Neuroendocrinology 2002;75:296-305.
18. Gery S, Virk RK, Chumakov K, Yu A, Koeffler HP. The clock gene Per2 links the circadian system to the estrogen receptor. Oncogene 2007;26:7916-20.
19. Cai W, Rambaud J, Teboul M, Masse I, Benoit G, Gustafsson JA, Delaunay F, Laudet V, Pongratz I. Expression levels of estrogen receptor beta are modulated by components of the molecular clock. Mol Cell Biol 2008;28:784-93.
20. Megdal SP, Kroenke CH, Laden F, Pukkala E, Schernhammer ES. Night work and breast cancer risk: a systematic review and meta-analysis. Eur J Cancer 2005;41:2023-32.
21. Hunt T, Sassone-Corsi P. Riding tandem: circadian clocks and the cell cycle. Cell 2007;129:461-4.
22. Sahar S, Sassone-Corsi P. Circadian clock and breast cancer: a molecular link. Cell Cycle 2007;6:1329-31.
23. Kaasik K, Lee CC. Reciprocal regulation of haem biosynthesis and the circadian clock in mammals. Nature 2004;430:467-71.
24. Koutros S, Holford TR, Hahn T, Lantos PM, McCarthy PL, Jr, Risch HA, Swede H. Excess diagnosis of non-Hodgkin's lymphoma during spring in the USA. Leuk Lymphoma 2007;48:357-66.
25. Muñoz M, Peirson SN, Hankins MW, Foster RG. Long-term constant light induces constitutive elevated expression of mPER2 protein in the murine SCN: a molecular basis for Aschoff's rule? J Biol Rhythms 2005;20:3-14.
26. Arjona A, Sarkar DK. The circadian gene mPer2 regulates the daily rhythm of IFN-γ. J Interferon Cytokine Res 2006;26:645-9.
27. Davidson AJ, Sellix MT, Daniel J, Yamazaki S, Menaker M, Block GD Chronic jet-lag increases mortality in aged mice. Curr Biol 2006;16:R914-R916.
28. Smedby KE, Hjalgrim H, Melbye M, Torrång A, Rostgaard K, Munksgaard L, Adami J, Hansen M, Porwit-MacDonald A, Jensen BA, Roos G, Pedersen BB, et al. Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst 2005;97:199-209.
29. Zhang Y, Holford TR, Leaderer B, Boyle P, Zhu Y, Wang R, Zou K, Zhang B, Wise JP Sr, Qin Q, Kilfoy B, Han J, et al. Ultraviolet radiation exposure and risk of non-Hodgkin's lymphoma. Am J Epidemiol 2007;165:1255-64.
30. Kricker A, Armstrong BK, Hughes AM, Goumas C, Smedby KE, Zheng T, Spinelli JJ, De Sanjosé S, Hartge P, Melbye M, Willen EV, Becker N, et al. for the Interlymph Consortium. Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium. Int J Cancer 2008;122:144-54.
31. Karipidis KK, Benke G, Sim MR, Kauppinen T, Kricker A, Hughes AM, Grulich AE, Vajdic CM, Kaldor J, Armstrong B, Fritschi L. Occupational exposure to ionizing and non-ionizing radiation and risk of non-Hodgkin lymphoma. Int Arch Occup Environ Health 2007;80:663-70.